Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
JNJ-31020028
Cat. No.:
OB0225LY-0003
Appearance:
Solid
Purity:
≥96%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
JNJ-31020028 is is a selective brain penetrant antagonist of neuropeptide Y2 receptor.
Synonym:
JNJ 31020028; 1094873-14-9; N-[4-[4-[2-(Diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl]-3-fluorophenyl]-2-pyridin-3-ylbenzamide; CHEMBL1823342; N-(4-(4-((N, N-Diethylcarbamoyl)(phenyl)methyl)piperazin-1-yl)-3-fluorophenyl)-2-(pyridin-3-yl)benzamide; N-(4-(4-(2-(Diethylamino)-2-oxo-1-phenylethyl)piperazin-1-yl)-3-fluorophenyl)-2-(pyridin-3-yl)benzamide; 1-Piperazineacetamide, N, N-diethyl-4-(2-fluoro-4-((2-(3-pyridinyl)benzoyl)amino)phenyl)-alpha-phenyl-; (-)-N-{4-[4-(Diethylcarbamoyl-phenyl-methyl)-piperazin-1-yl]-3-fluoro-phenyl}-2-pyridin-3-yl-benzamide; N-{4-[4-(Diethylcarbamoyl-phenyl-methyl)-piperazin-1-yl]-3-fluoro-phenyl}-2-pyridin-3-yl-benzamide
CAS No.:
1094873-14-9
Compound CID:
25134625
Formula:
C34H36FN5O2
Formula Weight:
565.68
Specification
Relative Density:
1.228 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
JNJ-31020028 can be used as an experimental compound to investigate immune response modulation for autoimmune diseases.
Library Information
Targets:
Neuropeptide Y receptor
Receptors:
Neuropeptide Y2 receptor
Pathways:
GPCR/G protein; Neuronal signaling
Plate Number:
AOCL-1
Plate Location:
a4
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
5.5 mg/mL; 9.72 mM
